18 November 2014 - US molecular diagnostics company CombiMatrix Corp (NASDAQ:CBMX) said Tuesday it had entered the in-vitro fertilisation (IVF) market with the launch of its pre-implantation genetic screening
(PGS) test for women undergoing IVF, CombiPGS.
Evidence is piling up that this practice, known as preimplantation genetic screening
(PGS), increases implantation and decreases miscarriage rates.
Patients with an established risk of disease, for example, because of family history, may be able to obtain genetic screening
on the NHS.
(NYSE: NVTA) has agreed to acquire California-based Singular Bio, Inc., a developer of single molecule detection technology, to increase access to genetic screening
in early pregnancy, the company said.
Researchers from general obstetrics and gynecology (ob.gyn.) practices in New York and Connecticut have shown that a 4-week intervention may improve genetic screening
and testing rates for hereditary breast and ovarian cancers (HBOC).
RIYADH: Princess Haifa bint Faisal, chairwoman of Zahra Breast Cancer Association, said that in the future, a breast cancer campaign will focus on genetic screening
as the association launched its 2018 Breast Cancer Awareness Campaign in Riyadh.
should be done in people who have a family history of heart diseases.
We conducted a study of 103 children--56 boys and 47 girls, aged 5 months to 9 years (mean: 4.1 yr)--with SNHL who underwent genetic screening
for 20 hot-spot mutations of the GJB2, SLC26A4, GJB3, and MT-RNR1 genes.
To date, more than 5,700 genetic screening
tests have been performed and patients identified with genetic alterations have been enrolled in many targeted therapy clinical trials.
In the May 2015 issue of MLO [2015;47(5):14] we reviewed the evolution of prenatal genetic screening
. The closing line of that article stated that "...
The genetic screening
chip, developed by scientists at the University of Edinburgh's Roslin Institute, will collect a sample from each oyster to help farmers breed oysters that can resist herpes.
THE FOOD AND DRUG ADMINISTRATION authorized 23andMe's Personal Genome Service Genetic Health Risk (GHR) test, the first direct-to-consumer genetic screening
test, according to a press release on Thursday, April 6.